<DOC>
	<DOCNO>NCT01822613</DOCNO>
	<brief_summary>To study safety efficacy combination LJM716 BYL719 currently available treatment physician 's choice previously treat esophageal squamous cell carcinoma patient .</brief_summary>
	<brief_title>Study Safety &amp; Efficacy Combination LJM716 &amp; BYL719 Patients With Previously Treated Esophageal Squamous Cell Carcinoma ( ESCC )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Histologically confirm esophageal squamous cell carcinoma ( ESCC ) No one prior chemotherapy regimen recurrent metastatic ESCC ( Phase II ) . Progression platinumbased therapy recurrent metastatic ESCC , recurrence within 6 month platinumbased chemotherapy chemoradiotherapy localize disease . Patients receive prior phosphoinositide3kinase ( PI3K ) inhibitor antireceptor tyrosineprotein kinase erbB3 ( ERBB3 HER3 ) antibody treatment , include bispecific antibody HER3 one target ( patient prior exposure pertuzumab epidermal growth factor receptor ( EGFR ) target agent eligible ) Patients archival fresh tumor sample ( section ) available readily obtainable . Patients central nervous system ( CNS ) metastatic involvement . Patients receive prior systemic anticancer treatment , cyclical chemotherapy biological therapy within period time short cycle length use treatment ( e.g . 6 week nitrosourea , mitomycinC ) prior start study treatment . Patients receive definitive radiotherapy ≤ 4 week prior start study drug , recover side effect therapy and/or ≥ 30 % bone marrow irradiate . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>esophageal cancer</keyword>
</DOC>